Ernexa Therapeutics Inc.
Organization details
- Legal name
- Ernexa Therapeutics Inc.
- Former names
- Eterna Therapeutics Inc. Brooklyn ImmunoTherapeutics, Inc. NTN Buzztime Inc NTN Communications Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Cambridge
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ERNA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000748592
- EIN
- 31-1103425
Board of directors
-
Brant Binder · DirectorSince 2023
-
David Polinsky · DirectorSince 2026
-
Dorothy J. Clarke · Director · General CounselSince 2023
-
Elena Ratner · DirectorSince 2025
-
James Arthur Bristol · DirectorSince 2023
-
Matthew Angel · Director · President and CEOSince 2023
-
Peter Cicala · DirectorSince 2024
-
Richard W. Wagner · DirectorSince 2023
-
Robert J. Spiegel · DirectorSince 2026
-
Sanjeev Luther · Director · President and CEOSince 2024
-
William A. Wexler · DirectorSince 2025
Chief executives
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 100
755.9% a year in revenue
20% of the scoring weight is on file. Figures cover December 2023 – December 2024.
Director election results
Annual meeting of October 29, 2024. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
91.0%
-
92.0%
-
93.0%
-
93.5%
-
98.5%
Board connections
3 of this board's directors also sit on 5 other boards. 4 are in the same sector.
- via Robert J. Spiegel
-
Erasca Inc. Same sectorvia James Arthur Bristol
-
Geron Corporation Same sectorvia Robert J. Spiegel
-
RenovoRx Inc. Same sectorvia Robert J. Spiegel
-
Tempest Therapeutics Inc. Same sectorvia Matthew Angel
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $2,000,000
- 1 purchase by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 10, 2026 | Cherington Charles 10% owner | Open-market purchase | +4,000,000 | $0.50 | $2,000,000 |
| Jun 21, 2025 | Gurrola Sandra M Officer (Sr. VP of Finance) | Option exercise | +30 | — | — |
| Jun 9, 2025 | Cherington Charles 10% owner | Open-market purchase | +21,241,163 | $0.10 | $2,124,116 |
| Apr 2, 2025 | Cherington Charles 10% owner | Open-market purchase | +3,768,397 | $0.10 | $376,840 |
| Oct 29, 2024 | Cherington Charles 10% owner | Open-market purchase | +261,756 | — | — |
| Oct 29, 2024 | Cherington Charles 10% owner | Open-market purchase | +4,768,783 | — | — |
| Oct 29, 2024 | Cherington Charles 10% owner | Open-market purchase | +1,237,762 | — | — |
| Oct 29, 2024 | Cherington Charles 10% owner | Open-market purchase | +5,420,823 | — | — |
| Oct 29, 2024 | Cherington Charles 10% owner | Open-market purchase | +1,562,988 | — | — |
| Oct 29, 2024 | Cherington Charles 10% owner | Derivative conversion | +2,819,546 | $0.50 | $1,409,773 |
| Jun 21, 2024 | Gurrola Sandra M Officer (Sr. VP of Finance) | Option exercise | +437 | — | — |
| Jun 21, 2024 | Gurrola Sandra M Officer (Sr. VP of Finance) | Shares withheld for tax | −180 | $1.94 | $349 |
| Jun 21, 2023 | Gurrola Sandra M Officer (Vice President of Finance) | Option exercise | +438 | — | — |
| Jun 21, 2023 | Gurrola Sandra M Officer (Vice President of Finance) | Shares withheld for tax | −179 | $2.48 | $444 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Ernexa Therapeutics Inc.
Who is the CEO of Ernexa Therapeutics Inc.?
Sanjeev Luther has been Ernexa Therapeutics Inc.'s President and CEO since January 2024.
How many directors are on Ernexa Therapeutics Inc.'s board?
Ernexa Therapeutics Inc.'s board has 11 directors: Brant Binder, David Polinsky, Dorothy J. Clarke, Elena Ratner, James Arthur Bristol, Matthew Angel, Peter Cicala, Richard W. Wagner, Robert J. Spiegel, Sanjeev Luther and 1 other.
Are Ernexa Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Ernexa Therapeutics Inc. insiders bought $2.0 million of shares in 1 purchase and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="ernexa-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.